Nova Peptides

Latest sync: Sep 18, 2026, 9:33 PM. Source coverage currently reflects PB Evidence data.

Curated
Independent evidence reviewRead the independent Nova Peptides evidence review
Transparency type
Third-party-linked reports
Access pattern
Publicly inspectable
Best for

Readers who want an openly priced U.S. research catalog with clear house-label mappings and a centralized /coas/ archive that can be checked at Freedom Diagnostics.

Fulfillment

Vendor-stated U.S.-made positioning and U.S. overnight shipping; support at [email protected]. No street-level public address verified. No PeptideBenchmark affiliate relationship. Research-use-only. Observed September 18, 2026.

Watch-out

GLP-1 SM / GLP-2 TZ / GLP-3 RT / SUPER-31 are branded storefront labels for semaglutide / tirzepatide / retatrutide / SS-31. This storefront is not Nova Life Peptides and not NovaPeptide.us. Eligible sprays, capsule/dry-fill units, and hCG appear in separate Ready sprays, Capsules, and IU hormones tabs on Pricing; they are not mixed into the vial $/mg lane. Some published certificates are vendor-hosted Ethos Analytics or previous-supplier reports rather than Freedom-verified lots.

A U.S. research storefront with openly priced vial strengths, clear GLP house labels, and a public /coas/ archive whose Freedom Diagnostics certificates resolve under the Nova Peptides client name.

Nova Peptides sells research-only singles and blends with prices and milligram strengths listed on the public catalog, including house labels GLP-1 SM, GLP-2 TZ, GLP-3 RT, and SUPER-31 for semaglutide, tirzepatide, retatrutide, and SS-31. The public /coas/ archive and downloadable PDFs publish third-party certificates; PeptideBenchmark confirms Freedom Diagnostics Nova* search codes under the Nova Peptides client name where lookup succeeds. Distinct from Nova Life Peptides (novalifepeptides.com) and from NovaPeptide (novapeptide.us).

Testing transparency
Vendor-hosted public documents
Public Verification
Publicly inspectable
Public COA archive with Freedom Diagnostics provider verification

The public /coas/ archive and matching media PDFs publish third-party certificates. PeptideBenchmark independently confirms Freedom Diagnostics search codes against the laboratory register under Nova Peptides and re-checks them on the normal trust cadence. Ethos Analytics and previous-supplier Vanguard reports remain vendor-hosted documents without a public laboratory lookup PeptideBenchmark can confirm. Two Freedom lots (2606120543, 2607080125) report no analyte detected at 0.00% and remain in the public record. A matched certificate documents the tested sample and does not endorse every vial.

Products reviewed
83
Products with certificates
83
Recommended examples
184
Vendor-hosted PDFs
59

This vendor is one of 119 names currently included in our manual curated research-vendor layer.

View curated vendor pageView transparency viewView compare page

This is the strongest public transparency pattern on the site. The key signal is that readers can leave the vendor domain and inspect reports or verification pages on an outside provider domain without needing to log in.

  • Treat the outside provider route as the strongest part of the evidence, not the vendor marketing copy around it.
  • Look for repeated product-level behavior across the catalog, not just one showcase example.
  • Do not overread it as proof that every current lot is covered or current unless the linked report trail itself supports that.
Read transparency methodologyBrowse similar transparency patterns

This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.

Open vendor compareOpen vendor/provider bridge

PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.

Strong curated case

Nova Peptides is currently one of the strongest curated cases on the site because readers can inspect a repeatable public evidence trail without logging in.

Evidence access
Open public verification
Verification structure
Provider-linked
Evidence depth
Broad
Lab context
Multi-lab or multi-category
Evidence access
Open public verification

Readers can leave the vendor marketing layer and inspect verification publicly.

Verification structure
Provider-linked

This is the strongest public pattern because the verification step routes into an outside provider layer.

Evidence depth
Broad

Current review touched 83 products and 184 document/link destinations.

Lab context
Multi-lab or multi-category

3 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.

How to read this benchmark

This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.

A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.

Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.